Cargando…

Curcumin inhibits spike protein of new SARS-CoV-2 variant of concern (VOC) Omicron, an in silico study

BACKGROUND: Omicron (B.1.1.529), a variant of SARS-CoV-2 is currently spreading globally as a dominant strain. Due to multiple mutations at its Spike protein, including 15 amino acid substitutions at the receptor binding domain (RBD), Omicron is a variant of concern (VOC) and capable of escaping vac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nag, Anish, Banerjee, Ritesh, Paul, Subhabrata, Kundu, Rita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9044632/ https://www.ncbi.nlm.nih.gov/pubmed/35508082 http://dx.doi.org/10.1016/j.compbiomed.2022.105552

Ejemplares similares

In silico study of some selective phytochemicals against a hypothetical SARS-CoV-2 spike RBD using molecular docking tools
por: Nag, Anish, et al.
Publicado: (2021)

In Silico Analysis of the Apoptotic and HPV Inhibitory Roles of Some Selected Phytochemicals Detected from the Rhizomes of Greater Cardamom
por: Nag, Anish, et al.
Publicado: (2022)

The ins and outs of SARS-CoV-2 variants of concern (VOCs)
por: Salehi-Vaziri, Mostafa, et al.
Publicado: (2022)

Phytochemicals as potential drug candidates for targeting SARS CoV 2 proteins, an in silico study
por: Nag, Anish, et al.
Publicado: (2021)

Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
por: Jimenez Ruiz, Jose A., et al.
Publicado: (2022)

An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant
por: Shishir, Tushar Ahmed, et al.
Publicado: (2022)

Emerging SARS-CoV-2 Variants of Concern (VOCs): An Impending Global Crisis
por: Thye, Angel Yun-Kuan, et al.
Publicado: (2021)

Is Omicron the last SARS-CoV-2 Variant of Concern?
por: Rahimi, Farid, et al.
Publicado: (2022)

Potent and broad neutralization of SARS-CoV-2 variants of concern (VOCs) including omicron sub-lineages BA.1 and BA.2 by biparatopic human VH domains
por: Chen, Chuan, et al.
Publicado: (2022)

Effective vaccination strategy using SARS-CoV-2 spike cocktail against Omicron and other variants of concern
por: Shi, Juan, et al.
Publicado: (2022)

Dynamics of SARS-CoV-2 variants of concern (VOC) in Bangladesh during the first half of 2021
por: Afrin, Sultana Zahura, et al.
Publicado: (2022)

Omicron SARS-CoV-2 Variants in an In Silico Genomic Comparison Study with the Original Wuhan Strain and WHO-Recognized Variants of Concern
por: Elssaig, Elmutuz H., et al.
Publicado: (2022)

In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern
por: Rajpoot, Sajjan, et al.
Publicado: (2021)

Omicron: A SARS‐CoV‐2 variant of real concern
por: Gattinger, Pia, et al.
Publicado: (2022)

Structure-guided design of multi-epitopes vaccine against variants of concern (VOCs) of SARS-CoV-2 and validation through In silico cloning and immune simulations
por: Humayun, Fahad, et al.
Publicado: (2022)

SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron
por: Mazzoni, Alessio, et al.
Publicado: (2022)

The Spike of Concern—The Novel Variants of SARS-CoV-2
por: Winger, Anna, et al.
Publicado: (2021)

Omicron: a mysterious variant of concern
por: Gowrisankar, A., et al.
Publicado: (2022)

Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?
por: Jung, Christoph, et al.
Publicado: (2022)

Chloroform fraction of Chaetomorpha brachygona, a marine green alga from Indian Sundarbans inducing autophagy in cervical cancer cells in vitro
por: Majumder, Indira, et al.
Publicado: (2020)

SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC)
por: Charonis, Spyros A., et al.
Publicado: (2022)

Characteristic analysis of Omicron‐included SARS‐CoV‐2 variants of concern
por: Yang, Hao, et al.
Publicado: (2022)

Omicron SARS-CoV-2 Variant Spike Protein Shows an Increased Affinity to the Human ACE2 Receptor: An In Silico Analysis
por: Ortega, Joseph Thomas, et al.
Publicado: (2021)

Detection of Circulating SARS-CoV-2 Variants of Concern (VOCs) Using a Multiallelic Spectral Genotyping Assay
por: Chrysostomou, Andreas C., et al.
Publicado: (2023)

A tool for the cheap and rapid screening of SARS-CoV-2 variants of concern (VoCs) by Sanger sequencing
por: Burgos, Germán, et al.
Publicado: (2023)

Dynamics of Early Establishment of SARS-CoV-2 VOC Omicron Lineages in Minas Gerais, Brazil
por: de Menezes, Mariane Talon, et al.
Publicado: (2023)

Increased immune escape of the new SARS-CoV-2 variant of concern Omicron
por: Hu, Jie, et al.
Publicado: (2022)

Omicron Variant Escapes Therapeutic Monoclonal Antibodies (mAbs) Including Recently Released Evusheld(®), Contrary to 8 Prior Main Variant of Concern (VOC)
por: Boschi, Céline, et al.
Publicado: (2022)

Household clustering of SARS-CoV-2 variant of concern B.1.1.7 (VOC-202012–01) in England
por: Chudasama, Dimple Y., et al.
Publicado: (2021)

SARS-CoV-2 multiplex RT-PCR to detect variants of concern (VOCs) in Malaysia, between January to May 2021
por: Fu, Jolene Yin Ling, et al.
Publicado: (2022)

131. Antiviral NL-CVX1 Efficiently Blocks Infection of SARS-CoV-2 Viral Variants of Concern (VOC)
por: Su, Wen, et al.
Publicado: (2021)

The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies
por: Focosi, Daniele, et al.
Publicado: (2022)

A tabulated summary of the evidence on humoral and cellular responses to the SARS-CoV-2 Omicron VOC, as well as vaccine efficacy against this variant.
por: Minka, S.O, et al.
Publicado: (2022)

Spike protein-independent attenuation of SARS-CoV-2 Omicron variant in laboratory mice
por: Liu, Shufeng, et al.
Publicado: (2022)

Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI)
por: Caza, Mélissa, et al.
Publicado: (2021)

Dynamics of SARS-CoV-2 VOC Neutralization and Novel mAb Reveal Protection against Omicron
por: Hao, Linhui, et al.
Publicado: (2023)

Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile
por: Alkhatib, Mohammad, et al.
Publicado: (2022)

Stability of SARS-CoV-2 variants of concern (Delta and Omicron) on surfaces at room temperature
por: Pottage, Thomas, et al.
Publicado: (2023)

In silico identification of deep-sea fungal alkaloids as potential inhibitors of SARS-CoV-2, Delta and Omicron spikes
por: Alanzi, Abdullah R, et al.
Publicado: (2023)

SARS-CoV-2 Omicron Variant of Concern: Everything You Wanted to Know about Omicron but Were Afraid to Ask
por: Shin, Dong Hoon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2m1d2vf0ek63n4sqq461lgi0n3